NCT04074642View on ClinicalTrials.gov

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 14, 2019

Primary Completion Date

February 22, 2023

Study Completion Date

February 22, 2023

Conditions

Pituitary Adenoma

Interventions

PROCEDURE

Neurosurgery

adenoma removal

Trial Locations (2)

06000

CHU de NICE, Nice

06001

Hôpital Pasteur 2 - Service d'Ophtalmologie, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04074642 - OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. | Biotech Hunter | Biotech Hunter